Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3375 of 3546 entries
View as:

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01390896 Org: User:
Start: 09/30/09 End: 01/31/13 Due: 01/31/14

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Phase: N/A Priority: Normal
NCT ID: NCT01196026 Org: User:
Start: 09/15/10 End: 05/26/11 Due: 05/26/12

Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01254032 Org: User:
Start: 08/31/10 End: 11/30/11 Due: 11/30/12

Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children

Phase: N/A Priority: Normal
NCT ID: NCT01159925 Org: User:
Start: 07/31/09 End: 12/31/11 Due: 12/31/12

GSK962040 Drug-drug Interaction Study With Ketoconazole

Phase: N/A Priority: Normal
NCT ID: NCT01039974 Org: User:
Start: 09/18/09 End: 11/30/09 Due: 11/30/10

Brain Metastasis in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01077648 Org: User:
Start: 02/28/10 End: 08/31/13 Due: 08/31/14

Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02113436 Org: User:
Start: 05/01/14 End: 10/01/16 Due: 10/01/17

Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients

Phase: N/A Priority: Normal
NCT ID: NCT00441974 Org: User:
Start: 12/31/06 End: 09/30/08 Due: 09/30/09

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT00529568 Org: User:
Start: 10/31/07 End: 08/31/11 Due: 08/31/12

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00619424 Org: User:
Start: 11/15/07 End: 09/04/09 Due: 09/04/10

Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health

Phase: N/A Priority: Normal
NCT ID: NCT02752958 Org: User:
Start: 05/23/16 End: 02/03/17 Due: 02/03/18

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02094937 Org: User:
Start: 03/27/14 End: 08/28/15 Due: 08/28/16

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Phase: N/A Priority: Normal
NCT ID: NCT00306293 Org: User:
Start: 02/20/06 End: 11/27/06 Due: 11/27/07

Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

Phase: N/A Priority: Normal
NCT ID: NCT00474864 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)

Phase: N/A Priority: Normal
NCT ID: NCT03368053 Org: User:
Start: 12/14/17 End: 01/30/18 Due: 01/30/19

Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01395875 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03305419 Org: User:
Start: 10/11/17 End: 10/15/18 Due: 10/15/19

ULTIVA Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01299584 Org: User:
Start: 09/30/05 End: 04/30/10 Due: 04/30/11

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

Phase: N/A Priority: Normal
NCT ID: NCT00158808 Org: User:
Start: 01/31/05 End: 04/30/05 Due: 04/30/06

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03893565 Org: User:
Start: 05/06/19 End: 05/17/21 Due: 05/17/22

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01436071 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00256880 Org: User:
Start: 01/31/05 End: 12/31/05 Due: 12/31/06

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

Phase: N/A Priority: Normal
NCT ID: NCT03183492 Org: User:
Start: 05/07/18 End: 01/28/19 Due: 01/28/20

Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00296517 Org: User:
Start: 01/19/06 End: 03/28/08 Due: 03/28/09

European Cost of Asthma Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01376219 Org: User:
Start: 01/31/10 End: 12/31/11 Due: 12/31/12